Removing of the N-terminal methionine improves the sweetness of the recombinant expressed sweet-tasting protein brazzein and its mutants in Escherichia coli
The sweet-tasting protein brazzein is the smallest candy protein with excessive candy efficiency. Overexpression of this protein in a heterogenous host is a vital means for its manufacturing in meals trade. On this research, the gene of minor kind brazzein was cloned into the pET-SUMO vector with optimized codon utilization and expressed in E. coli BL21-CodonPlus (DE3)-RIL.
The recombinant protein in absence of the N-terminal methionine displayed a sweetness threshold about 1.5 μg/ml, which is the sweetest brazzein protein reported to date. The surprising candy efficiency of the protein was validated by a sequence of mutants (7Val → Arg, 9Glu → Lys and 9Glu → Asp), wherein E9K exhibited about 50% enhancement of sweetness than the wild sort. The superior sweetness of recombinant brazzein and its sweeter mutants counsel their potential purposes in meals and drinks.
PRACTICAL APPLICATIONS: The sweet-tasting proteins are pure, low-, or non-caloric and nutritive, exhibiting to be promising replacers of sugars and synthetic sweeteners, and can be utilized as candy components within the fields of meals, drugs, and biotechnology. Within the current research, we report that the recombinant brazzein protein expressed in E. coli reveals superior and improved sweetness than these beforehand reported.
Moreover, sweeter mutants had been obtained with the expression process. The superior sweetness of recombinant brazzein and its sweeter mutants counsel their potential purposes in meals, drinks, and different fields.
Key phrases: E. coli expression; N-terminus; mutant; sweet-tasting protein brazzein; sweetness
Yeast AHA1 Protein |
|||
| SPR-314C | Stressmarq | 2x0.1 mg | EUR 676.8 |
|
Description: His tagged recombinant yeast AHA1 Protein expressed in E. coli for WB, SDS-PAGE, Functional Assay. The biological activity of this protein has not yet been tested. |
|||
GLC8 Yeast Recombinant Protein |
|||
| PROTP41818 | BosterBio | Regular: 50ug | EUR 380.4 |
|
Description: GLC8 Yeast (Saccharomyces cerevisiae) Recombinant produced in E.coli is a single, glycosylated polypeptide chain containing 265 amino acids (1-229) and having a molecular mass of 30.7 kDa (molecular size on SDS-PAGE will appear higher). ;The GLC8 is fused to a 35 amino acid His Tag at N-Terminus and purified by standard chromatography techniques. |
|||
Recombinant Yeast IDH1 Protein, Untagged, Yeast-50mg |
|||
| QP10670-50mg | EnQuireBio | 50mg | EUR 1251.6 |
Recombinant Yeast IDH1 Protein, Untagged, Yeast-1mg |
|||
| QP10670-1mg | EnQuireBio | 1mg | EUR 186 |
Recombinant Yeast IDH1 Protein, Untagged, Yeast-5mg |
|||
| QP10670-5mg | EnQuireBio | 5mg | EUR 241.2 |
Recombinant Yeast GLRX1 Yeast Protein, His, E.coli-1mg |
|||
| QP11990-1mg | EnQuireBio | 1mg | EUR 1873.2 |
Recombinant Yeast GLRX2 Yeast Protein, His, E.coli-1mg |
|||
| QP11991-1mg | EnQuireBio | 1mg | EUR 1873.2 |
Recombinant Yeast GLRX1 Yeast Protein, His, E.coli-10ug |
|||
| QP11990-10ug | EnQuireBio | 10ug | EUR 186 |
Recombinant Yeast GLRX1 Yeast Protein, His, E.coli-50ug |
|||
| QP11990-50ug | EnQuireBio | 50ug | EUR 241.2 |
Recombinant Yeast GLRX2 Yeast Protein, His, E.coli-10ug |
|||
| QP11991-10ug | EnQuireBio | 10ug | EUR 186 |
Recombinant Yeast GLRX2 Yeast Protein, His, E.coli-50ug |
|||
| QP11991-50ug | EnQuireBio | 50ug | EUR 241.2 |
Yeast Kex-2 Recombinant Protein |
|||
| 40-539-005mg | ProSci | 0.05 mg | EUR 311.1 |
|
Description: Proteases (also called Proteolytic Enzymes, Peptidases, or Proteinases) are enzymes that hydrolyze the amide bonds within proteins or peptides. Most proteases act in a specific manner, hydrolyzing bonds at or adjacent to specific residues or a specific sequence of residues contained within the substrate protein or peptide. Proteases play an important role in most diseases and biological processes including prenatal and postnatal development, reproduction, signal transduction, the immune response, various autoimmune and degenerative diseases, and cancer. They are also an important research tool, frequently used in the analysis and production of proteins. Kex-2 cleaves at the carboxyl end of the recognition sequences Arg-Arg/X and Lys-Arg/X. Recombinant Yeast Kex-2 is a 59.9 kDa protease consisting of 554 amino acid residues. |
|||
Yeast Kex-2 Recombinant Protein |
|||
| 40-539-025mg | ProSci | 0.25mg | EUR 437.1 |
|
Description: Proteases (also called Proteolytic Enzymes, Peptidases, or Proteinases) are enzymes that hydrolyze the amide bonds within proteins or peptides. Most proteases act in a specific manner, hydrolyzing bonds at or adjacent to specific residues or a specific sequence of residues contained within the substrate protein or peptide. Proteases play an important role in most diseases and biological processes including prenatal and postnatal development, reproduction, signal transduction, the immune response, various autoimmune and degenerative diseases, and cancer. They are also an important research tool, frequently used in the analysis and production of proteins. Kex-2 cleaves at the carboxyl end of the recognition sequences Arg-Arg/X and Lys-Arg/X. Recombinant Yeast Kex-2 is a 59.9 kDa protease consisting of 554 amino acid residues. |
|||
TM Yeast Pst1 Recombinant Protein |
|||
| 95-151 | ProSci | 0.05 mg | EUR 386.7 |
|
Description: Protoplast secreted protein 1 (Pst1) is an anchored plasma membrane protein. Pst1 was previously identified as a protein secreted by yeast regenerating protoplasts, which suggests a role in cell wall construction (1). Pst1 is a protein with 444 amino acids and is attached to yeast cell wall via a glycosylphosphatidylinisotol (GPI) anchor (2). Pst1 contains 15 potential N-linked glycosylation sites and is heavily glycosylated. It migrates at around 200 kDa on SDS-PAGE when produced in wild type S. cerevisiae. Our Pst1 protein was expressed in a genetically manipulated triple-mutant (TM) S. cerevisiae stain (Δoch1 Δmnn1 Δmnn4), which results in the production of sole Man8GlcNAc2 carbohydrate structures and Pst1 migration at approximately 100 kDa. When produced in the TM yeast, Pst1 can be recognized by several HIV-1 broadly neutralizing antibodies, including 2G12 and recently identified glycan-specific PGT antibodies (3). Among several heavily N-glycosylated TM yeast glycoproteins, Pst1 shows high affinity for 2G12 and efficiently inhibits gp120 interactions with 2G12 and DC-SIGN, and it also blocks 2G12-mediated neutralization of HIV-1 pseudoviruses (4). |
|||
Recombinant Yeast Kex-2 Protein |
|||
| PROTP13134 | BosterBio | 250ug | EUR 380.4 |
|
Description: Proteases (also called Proteolytic Enzymes, Peptidases, or Proteinases) are enzymes that hydrolyze the amide bonds within proteins or peptides. Most proteases act in a specific manner, hydrolyzing bonds at or adjacent to specific residues or a specific sequence of residues contained within the substrate protein or peptide. Proteases play an important role in most diseases and biological processes including prenatal and postnatal development, reproduction, signal transduction, the immune response, various autoimmune and degenerative diseases, and cancer. They are also an important research tool, frequently used in the analysis and production of proteins. Kex-2 cleaves at the carboxyl end of the recognition sequences Arg-Arg/X and Lys-Arg/X. Recombinant Yeast Kex-2 is a 60.4 kDa protease consisting of 558 amino acid residues. |
|||
Yeast Kex-2 Recombinant Protein |
|||
| P1279-250 | Biovision | each | EUR 510 |
Yeast Kex-2 Recombinant Protein |
|||
| P1279-50 | Biovision | each | EUR 210 |
Recombinant Saccharomyces Cerevisiae AHA1 Protein (aa 1-350) [His] |
|||
| VAng-Wyb4128-1mg | Creative Biolabs | 1 mg | EUR 5524.8 |
|
Description: Saccharomyces Cerevisiae (strain ATCC 204508 / S288c) Aha1p protein, recombinant protein. |
|||
TXN2 Thioredoxin-2 Yeast Recombinant Protein |
|||
| PROTP22803 | BosterBio | Regular: 20ug | EUR 380.4 |
|
Description: Thioredoxin-2 Yeast Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain having a molecular mass of 12.6kDa. |
|||
GLRX2 Glutaredoxin 2 Yeast Recombinant Protein |
|||
| PROTP17695 | BosterBio | Regular: 50ug | EUR 380.4 |
|
Description: Glutaredoxin-2 Saccharamyces cerevisiae Recombinant containing 6x His tag at C-terminus produced in E.Coli is a single, non-glycosylated, Polypeptide chain having a molecular mass of 17 kDa. |
|||
GLRX1 Glutaredoxin 1 Yeast Recombinant Protein |
|||
| PROTP25373 | BosterBio | Regular: 50ug | EUR 380.4 |
|
Description: Glutaredoxin Saccharamyces cerevisiae Recombinant containing 6x His tag at C-Terminus produced in E.Coli is a single, non-glycosylated, Polypeptide chain having a molecular mass of 16 kDa. |
|||
Recombinant Rat MMP7 Protein, His, Yeast-100ug |
|||
| QP6371-ye-100ug | EnQuireBio | 100ug | EUR 685.2 |
Recombinant Rat MMP7 Protein, His, Yeast-200ug |
|||
| QP6371-ye-200ug | EnQuireBio | 200ug | EUR 1077.6 |
Recombinant Rat MMP7 Protein, His, Yeast-500ug |
|||
| QP6371-ye-500ug | EnQuireBio | 500ug | EUR 1806 |
Recombinant Rat PTMA Protein, His, Yeast-100ug |
|||
| QP9354-ye-100ug | EnQuireBio | 100ug | EUR 685.2 |
Recombinant Rat PTMA Protein, His, Yeast-200ug |
|||
| QP9354-ye-200ug | EnQuireBio | 200ug | EUR 1077.6 |
Recombinant Rat PTMA Protein, His, Yeast-500ug |
|||
| QP9354-ye-500ug | EnQuireBio | 500ug | EUR 1806 |
Recombinant Rat Nqo2 Protein, His, Yeast-100ug |
|||
| QP7703-ye-100ug | EnQuireBio | 100ug | EUR 685.2 |
Recombinant Rat Nqo2 Protein, His, Yeast-200ug |
|||
| QP7703-ye-200ug | EnQuireBio | 200ug | EUR 1077.6 |
Recombinant Rat Nqo2 Protein, His, Yeast-500ug |
|||
| QP7703-ye-500ug | EnQuireBio | 500ug | EUR 1806 |
Recombinant Human Protein E7 Protein, His, Yeast-100ug |
|||
| QP7367-ye-100ug | EnQuireBio | 100ug | EUR 576 |
Recombinant Human Protein E7 Protein, His, Yeast-200ug |
|||
| QP7367-ye-200ug | EnQuireBio | 200ug | EUR 892.8 |
Recombinant Human Protein E7 Protein, His, Yeast-500ug |
|||
| QP7367-ye-500ug | EnQuireBio | 500ug | EUR 1447.2 |
Recombinant Human Protein E6 Protein, His, Yeast-100ug |
|||
| QP7409-ye-100ug | EnQuireBio | 100ug | EUR 576 |
Recombinant Human Protein E6 Protein, His, Yeast-200ug |
|||
| QP7409-ye-200ug | EnQuireBio | 200ug | EUR 892.8 |
Recombinant Human Protein E6 Protein, His, Yeast-500ug |
|||
| QP7409-ye-500ug | EnQuireBio | 500ug | EUR 1447.2 |
Recombinant Rat MMP7 Protein, His, Yeast-10ug |
|||
| QP6371-ye-10ug | EnQuireBio | 10ug | EUR 326.4 |
Recombinant Rat MMP7 Protein, His, Yeast-50ug |
|||
| QP6371-ye-50ug | EnQuireBio | 50ug | EUR 424.8 |
Recombinant Rat PTMA Protein, His, Yeast-10ug |
|||
| QP9354-ye-10ug | EnQuireBio | 10ug | EUR 326.4 |
Recombinant Rat PTMA Protein, His, Yeast-50ug |
|||
| QP9354-ye-50ug | EnQuireBio | 50ug | EUR 424.8 |
Recombinant Rat Nqo2 Protein, His, Yeast-10ug |
|||
| QP7703-ye-10ug | EnQuireBio | 10ug | EUR 326.4 |
Recombinant Rat Nqo2 Protein, His, Yeast-50ug |
|||
| QP7703-ye-50ug | EnQuireBio | 50ug | EUR 424.8 |
Recombinant Human Protein E7 Protein, His, Yeast-10ug |
|||
| QP7367-ye-10ug | EnQuireBio | 10ug | EUR 283.2 |
Recombinant Human Protein E7 Protein, His, Yeast-50ug |
|||
| QP7367-ye-50ug | EnQuireBio | 50ug | EUR 358.8 |
Recombinant Human Protein E6 Protein, His, Yeast-10ug |
|||
| QP7409-ye-10ug | EnQuireBio | 10ug | EUR 283.2 |
Recombinant Human Protein E6 Protein, His, Yeast-50ug |
|||
| QP7409-ye-50ug | EnQuireBio | 50ug | EUR 358.8 |
Recombinant E.coli Protein FimH Protein, His, Yeast-100ug |
|||
| QP7372-ye-100ug | EnQuireBio | 100ug | EUR 945.6 |
Recombinant E.coli Protein FimH Protein, His, Yeast-200ug |
|||
| QP7372-ye-200ug | EnQuireBio | 200ug | EUR 1512 |
Recombinant E.coli Protein FimH Protein, His, Yeast-500ug |
|||
| QP7372-ye-500ug | EnQuireBio | 500ug | EUR 2164.8 |
Recombinant E.coli nrdB Protein, His, Yeast-100ug |
|||
| QP6953-ye-100ug | EnQuireBio | 100ug | EUR 945.6 |
Recombinant E.coli nrdB Protein, His, Yeast-200ug |
|||
| QP6953-ye-200ug | EnQuireBio | 200ug | EUR 1512 |
Recombinant E.coli nrdB Protein, His, Yeast-500ug |
|||
| QP6953-ye-500ug | EnQuireBio | 500ug | EUR 2164.8 |
Recombinant E.coli plsC Protein, His, Yeast-100ug |
|||
| QP7206-ye-100ug | EnQuireBio | 100ug | EUR 945.6 |
Recombinant E.coli plsC Protein, His, Yeast-200ug |
|||
| QP7206-ye-200ug | EnQuireBio | 200ug | EUR 1512 |
Recombinant E.coli plsC Protein, His, Yeast-500ug |
|||
| QP7206-ye-500ug | EnQuireBio | 500ug | EUR 2164.8 |
Regenerative impact of recombinant human bone morphogenetic protein-2/absorbable collagen sponge (rhBMP-2/ACS) after sequestrectomy of medication-related osteonecrosis of the jaw (MRONJ)
Aims: Past the unique software permitted by the U.S. Meals and Drug Administration, recombinant human bone morphogenetic protein-2 (rhBMP-2) is used for medication-related osteonecrosis of the jaw (MRONJ) remedy due to its bone transforming enhancement properties. The aim of the research was to analyze the bone formation impact of rhBMP-2/absorbable collagen sponge (ACS) in sufferers with MRONJ.
Supplies and strategies: On this retrospective cohort research, 26 feminine sufferers recognized with MRONJ and who underwent mandibular sequestrectomy at Ajou College Dental Hospital from 2010 to 2018 had been included. The experimental group was composed of 18 sufferers who acquired rhBMP-2/ACSafter sequestrectomy, whereas the management group was composed of Eight sufferers who didn’t obtain rhBMP-2/ACS after sequestrectomy. A complete dose of 0.5 mg of rhBMP-2 was used within the experimental group at a focus of 0.5 mg/mL.
Observe-up panoramic X-rays had been taken instantly after the surgical procedure and greater than 6 months after the surgical procedure. Utilizing these X-rays, a radiographic index of bone defect space was calculated utilizing the modified Ihan Hren technique, which measures radiographic density of the conventional bone and the defect web site.
Outcomes: This research means that rhBMP-2 contributes to new bone formation. The imply radiographic index instantly after surgical procedure and greater than 6 months after the surgical procedure for the experimental group was 68.4% and 79.8%, respectively. The imply radiographic index instantly after surgical procedure and greater than 6 months after the surgical procedure for the management group was 73.4% and 76.7%, respectively (Wilcoxon signed rank take a look at, P>0.05). The imply radiographic index elevated 11.4% within the experimental group and three.27% within the management group (Mann-Whitney U-test, P <0.05).
Conclusion: Based mostly on the outcomes, use of rhBMP-2/ACS on bone defect websites after sequestrectomy might be a profitable technique for remedy of MRONJ sufferers.
Key phrases: Bisphosphonate-associated osteonecrosis of the jaw; Osteomyelitis; Osteonecrosis; Recombinant human bone morphogenetic protein-2.
Utility of the Leishmania infantum 21 kDa recombinant protein for the event of an immunochromatographic take a look at
Background: Visceral leishmaniasis (VL), brought on by Leishmania infantum is a systemic parasitic illness and presents a worldwide well being downside which might be deadly if not recognized and handled. Canine are the primary hosts and supply reservoirs for the transmission of the illness to people.
Strategies: On this research, the gene encoding a 21 kDa protein was cloned and expressed as a fusion protein in Escherichia coli pressure BL21 (DE3) for creating a speedy immunochromatographic take a look at (ICT) to establish contaminated canine.
The expression of the recombinant 21 kDa protein (r21) was investigated utilizing SDS-PAGE and western blotstrategies. The purified r21 kDa protein was noticed onto ICT strips and examined by sera from experimentally contaminated, naturally contaminated, and uninfected canine.
Outcomes: The SDS-PAGE and western blot strategies confirmed the profitable expression of r21 kDa protein. The ICT strip take a look at revealed that the r21 kDa protein was detected by the sera of experimentally and naturally contaminated canine. The specificity assessments additionally confirmed no cross-reactivity with animals contaminated with Trypanosoma cruzi, Toxoplasma gondii, and Ehrlichia canis.
Conclusions: Based mostly on these findings the brand new r21 kDa protein could also be an acceptable goal for creating a brand new easy, particular and speedy serological technique to detect VL in contaminated canine.
Key phrases: Leishmania infantum; 21 kDa protein; Canine; Immunochromatographic take a look at; Visceral leishmaniasis.
Human Alpha Synuclein A30P/A53T Recombinant double mutant protein |
|||
| SYN-A3053T-R | Alpha Diagnostics | 50ug | EUR 315.6 |
Recombinant purified Human Alpha Synuclein mutant protein (1-60 aa) |
|||
| SYN-160-R | Alpha Diagnostics | 50ug | EUR 315.6 |
Recombinant purified Human Alpha Synuclein mutant protein (1-95 aa) |
|||
| SYN-195-R | Alpha Diagnostics | 50ug | EUR 315.6 |
Recombinant purified Human Alpha Synuclein protein (140 aa full length, wild type) |
|||
| SYN11-R-50 | Alpha Diagnostics | 50 ug | EUR 343.2 |
Recombinant purified Human Alpha Synuclein mutant protein (Delta NAC/96-140 aa) |
|||
| SYN-96140-R | Alpha Diagnostics | 50ug | EUR 315.6 |
Recombinant (E.Coli) purified Mouse Alpha Synuclein protein (140 aa full length, wild type) |
|||
| SYN12-R-20 | Alpha Diagnostics | 20 ug | EUR 489.6 |
SNCA Alpha Synuclein Human Recombinant Protein |
|||
| PROTP37840-8 | BosterBio | Regular: 100ug | EUR 380.4 |
|
Description: a-Synuclein Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain of 140 amino acids having a molecular mass of 14.4kDa (Real molecular weight on SDS-PAGE will be shift up). ;The Recombinant Human a-Synuclein is purified by proprietary chromatographic techniques. |
|||
SNCA Alpha Synuclein 61-140 Human Recombinant Protein |
|||
| PROTP37840-5 | BosterBio | Regular: 50ug | EUR 380.4 |
|
Description: A-Synuclein 61-140 Human Recombinant which is a deletion mutant of the a-synuclein amino acids 61-140 , produced in E.Coli is a single, non-glycosylated polypeptide chain of 81 amino acids having a molecular mass of 8.4kDa (molecular size on SDS-PAGE will appear higher), with an additional Met attached at the N-terminus. The Recombinant Human a-Synuclein 61-140 is purified by proprietary chromatographic techniques. |
|||
SNCA Alpha Synuclein 96-140 Human Recombinant Protein |
|||
| PROTP37840-6 | BosterBio | Regular: 50ug | EUR 380.4 |
|
Description: A-Synuclein 96-140 Human Recombinant which is a deletion mutant of the a-synuclein amino acids 96-140, produced in E.Coli is a single, non-glycosylated polypeptide chain of 46 amino acids having a molecular mass of 5.2kDa, with an additional Met attached at the N-terminus. The Recombinant Human a-Synuclein 96-140 is purified by proprietary chromatographic techniques. |
|||
SNCA 21916 Alpha Synuclein 1-60 Human Recombinant Protein |
|||
| PROTP37840-7 | BosterBio | Regular: 50ug | EUR 380.4 |
|
Description: A-Synuclein 1-60 Human Recombinant which is a deletion mutant of the a-synuclein amino acids 1-60 and contains the N-terminal amphipathic domain, produced in E.Coli is a single, non-glycosylated polypeptide chain of 60 amino acids having a molecular mass of 6.1kDa. The Recombinant Human a-Synuclein 1-60 is purified by proprietary chromatographic techniques. |
|||
SNCA Alpha Synuclein NACP112 Human Recombinant Protein |
|||
| PROTP37840-4 | BosterBio | Regular: 20ug | EUR 380.4 |
|
Description: A-Synuclein NACP112 Human Recombinant which is an alternatively spliced (103-129) form of a-Synuclein, produced in E.Coli is a single, non-glycosylated polypeptide chain of 112 amino acids having a molecular mass of 11.3kDa. The Recombinant Human a-Synuclein NACP112 is purified by proprietary chromatographic techniques. |
|||
Purified recombinant Human beta Synuclein protein W. blot +ve Control |
|||
| SYN13-C | Alpha Diagnostics | 100ul | EUR 343.2 |
SNCA Alpha Synuclein Delta-NAC Human Recombinant Protein |
|||
| PROTP37840-3 | BosterBio | Regular: 50ug | EUR 380.4 |
|
Description: A-Synuclein Delta-NAC Human Recombinant which is a deletion mutant of the a-synuclein that lacks the NAC region (amino acid 61-95), produced in E.Coli is a single, non-glycosylated polypeptide chain of 111 amino acids having a molecular mass of 11.9kDa (molecular size on SDS-PAGE will appear higher), with 6 amino acids added as a linker. The Recombinant Human a-Synuclein Delta-NAC is purified by proprietary chromatographic techniques. |
|||
Recombinant Purified Human beta Synuclein protein full length (1-134 aa) |
|||
| SYN-25-R | Alpha Diagnostics | 50ug | EUR 315.6 |
Human Alpha Synuclein protein W. blot +ve control |
|||
| SYN11-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
Recombinant Purified Human Gamma Synuclein protein full length (1-127 aa) |
|||
| SYN-35-R | Alpha Diagnostics | 50ug | EUR 315.6 |
Recombinant Purified Mouse Gamma Synuclein protein full length |
|||
| SYN-36-R | Alpha Diagnostics | 50ug | EUR 315.6 |
Recombinant Synuclein Alpha (SNCa) |
|||
| 4-RPB222Hu01 | Cloud-Clone |
|
|
|
Description: Recombinant Human Synuclein Alpha expressed in: E.coli |
|||
Recombinant Synuclein Alpha (SNCa) |
|||
| 4-RPB222Mu01 | Cloud-Clone |
|
|
|
Description: Recombinant Mouse Synuclein Alpha expressed in: E.coli |
|||
Recombinant Synuclein Alpha (SNCa) |
|||
| 4-RPB222Ra01 | Cloud-Clone |
|
|
|
Description: Recombinant Rat Synuclein Alpha expressed in: E.coli |
|||
Recombinant Synuclein Alpha Interacting Protein 1 (SNCaIP1) |
|||
| 4-RPC859Ra01 | Cloud-Clone |
|
|
|
Description: Recombinant Rat Synuclein Alpha Interacting Protein 1 expressed in: E.coli |
|||
alpha+beta Synuclein recombinant monoclonal antibody |
|||
| A5623 | Bimake | 100ul X 3 | EUR 714 |
|
Description: A recombinant monoclonal antibody from rabbit against human alpha+beta Synuclein for WB ,ELISA |
|||
alpha Synuclein protein |
|||
| 30R-1000 | Fitzgerald | 100 ug | EUR 360 |
|
Description: Purified recombinant Human alpha Synuclein protein |
|||
alpha Synuclein protein |
|||
| 30R-1001 | Fitzgerald | 100 ug | EUR 360 |
|
Description: Purified recombinant Human alpha Synuclein protein |
|||
alpha synuclein protein |
|||
| 30R-3032 | Fitzgerald | 200 ug | EUR 424.8 |
|
Description: Purified recombinant alpha synuclein protein |
|||
Human alpha Synuclein 1-60 Protein |
|||
| 20-abx260429 | Abbexa |
|
|
alpha Synuclein 61140 protein |
|||
| 30R-1007 | Fitzgerald | 100 ug | EUR 268.8 |
|
Description: Purified recombinant Human alpha Synuclein 61140 protein |
|||
alpha Synuclein 96140 protein |
|||
| 30R-1008 | Fitzgerald | 100 ug | EUR 268.8 |
|
Description: Purified recombinant Human alpha Synuclein 96140 protein |
|||
alpha Synuclein 160 protein |
|||
| 30R-1009 | Fitzgerald | 100 ug | EUR 268.8 |
|
Description: Purified recombinant Human alpha Synuclein 160 protein |
|||
alpha Synuclein 195 protein |
|||
| 30R-1013 | Fitzgerald | 100 ug | EUR 268.8 |
|
Description: Purified recombinant Human alpha Synuclein 195 protein |
|||
Human Synuclein Alpha (SNCa) Protein |
|||
| 20-abx652152 | Abbexa |
|
|
Active Human Alpha Synuclein Protein Filaments |
|||
| SPR-450B | Stressmarq | 0.1 mg | EUR 477.6 |
|
Description: Untagged recombinant human Alpha Synuclein Protein expressed in E. coli for WB, SDS-PAGE, In vivo assay, In vitro assay. This protein is biologically active. |
|||
Active Human Alpha Synuclein Protein Filaments |
|||
| SPR-450C | Stressmarq | 2x0.1 mg | EUR 717.6 |
|
Description: Untagged recombinant human Alpha Synuclein Protein expressed in E. coli for WB, SDS-PAGE, In vivo assay, In vitro assay. This protein is biologically active. |
|||
Active Human Alpha Synuclein Protein Filaments |
|||
| SPR-450E | Stressmarq | 5x0.1 mg | EUR 1376.4 |
|
Description: Untagged recombinant human Alpha Synuclein Protein expressed in E. coli for WB, SDS-PAGE, In vivo assay, In vitro assay. This protein is biologically active. |
|||
alpha Synuclein 61-140 Protein |
|||
| 20-abx260427 | Abbexa |
|
|
alpha Synuclein 96-140 Protein |
|||
| 20-abx260428 | Abbexa |
|
|
Human Gamma Synuclein protein W. blot +ve control |
|||
| SYN15-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
alpha Synuclein A30P Protein |
|||
| 20-abx260422 | Abbexa |
|
|